{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:36:43Z","timestamp":1793219803249,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"publisher","award":["CRG \/2022\/000911"],"award-info":[{"award-number":["CRG \/2022\/000911"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"publisher","award":["ANRF\/ARG\/2025\/002123\/LS"],"award-info":[{"award-number":["ANRF\/ARG\/2025\/002123\/LS"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbc.2026.113491","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:33:04Z","timestamp":1787700784000},"page":"113491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAK1-mediated phosphorylation of ARGLU1 promotes tumorigenic potential of breast cancer"],"prefix":"10.1016","volume":"302","author":[{"given":"Srikanth Swamy Swaroop","family":"B","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1763-8556","authenticated-orcid":false,"given":"Prarthana","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kanumuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abirami","family":"Seetharaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Kumar","family":"Rayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-9785","authenticated-orcid":false,"given":"Ganesh","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113491_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.113491_bib2","first-page":"1","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers 2019"},{"key":"10.1016\/j.jbc.2026.113491_bib3","doi-asserted-by":"crossref","first-page":"23934","DOI":"10.1074\/jbc.270.41.23934","article-title":"Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1","volume":"270","author":"Zhang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113491_bib4","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/onc.2009.119","article-title":"PAK signaling in oncogenesis","volume":"28","author":"Molli","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113491_bib5","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.7150\/thno.46913","article-title":"P21-activated kinase 1: emerging biological functions and potential therapeutic targets in Cancer","volume":"10","author":"Yao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2026.113491_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrc3645","article-title":"PAK signalling during the development and progression of cancer","volume":"14","author":"Radu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.113491_bib7","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/sj.onc.1209309","article-title":"PAK1 hyperactivation is sufficient for mammary gland tumor formation","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113491_bib8","article-title":"p21 activated kinase-1 and tamoxifen \u2013 a deadly nexus impacting breast cancer outcomes","volume":"1877","author":"Rajendran","year":"2022","journal-title":"Biochim. Biophys. Acta (Bba) - Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.113491_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144991","article-title":"Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers","volume":"760","author":"Kanumuri","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.jbc.2026.113491_bib10","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1158\/0008-5472.CAN-06-0978","article-title":"Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity","volume":"66","author":"Rayala","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113491_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jnci\/djj185","article-title":"Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients","volume":"98","author":"Holm","year":"2006","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbc.2026.113491_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2057-z","article-title":"FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine","volume":"16","author":"Yeo","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2026.113491_bib13","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/annonc\/mdw184","article-title":"P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer","volume":"27","author":"Jagadeeshan","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2026.113491_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41523-023-00556-9","article-title":"Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4\/6 inhibitors in ER+ breast cancer","volume":"9","author":"Belli","year":"2023","journal-title":"NPJ Breast Cancer."},{"key":"10.1016\/j.jbc.2026.113491_bib15","doi-asserted-by":"crossref","first-page":"17746","DOI":"10.1074\/jbc.M110.206029","article-title":"Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113491_bib16","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/nar\/gkz010","article-title":"ARGLU1 is a transcriptional coactivator and splicing regulator important for stress hormone signaling and development","volume":"47","author":"Magomedova","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113491_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103436","article-title":"Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data","volume":"69","author":"Li","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2026.113491_bib18","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1093\/nar\/gkae208","article-title":"ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair","volume":"52","author":"Bachus","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113491_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.129184","article-title":"DTL promotes head and neck squamous cell carcinoma progression by mediating the degradation of ARGLU1 to regulate the Notch signaling pathway","volume":"259","author":"Shi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jbc.2026.113491_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/1535-7163.MCT-24-0404","article-title":"Novel combination therapy targeting oncogenic signaling kinase P21-Activated kinase 1 and chemotherapeutic drugs against triple-negative breast cancer","volume":"24","author":"Ezhil","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2026.113491_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1083\/jcb.201412008","article-title":"Kinase-interacting substrate screening is a novel method to identify kinase substrates","volume":"206","author":"Amano","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jbc.2026.113491_bib22","first-page":"14.16.1","article-title":"Identification of protein kinase substrates by the kinase-interacting substrate screening (KISS) approach","volume":"2016","author":"Amano","year":"2016","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113491_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pmic.201200439","article-title":"Comet: an open-source MS\/MS sequence database search tool","volume":"13","author":"Eng","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.jbc.2026.113491_bib24","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/acs.jproteome.8b00175","article-title":"SearchGUI: a Highly Adaptable Common Interface for Proteomics Search and de Novo Engines","volume":"17","author":"Barsnes","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbc.2026.113491_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nbt.3109","article-title":"PeptideShaker enables reanalysis of MS-derived proteomics data sets: to the editor","volume":"33","author":"Vaudel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2026.113491_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.26502\/jbb.2642-91280119","article-title":"cProSite: a web based interactive platform for online proteomics, phosphoproteomics, and genomics data analysis","volume":"6","author":"Wang","year":"2023","journal-title":"J. Biotechnol. Biomed."},{"key":"10.1016\/j.jbc.2026.113491_bib27","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113491_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.jbc.2026.113491_bib29","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582602363X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582602363X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:31:26Z","timestamp":1793219486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582602363X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S002192582602363X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113491","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAK1-mediated phosphorylation of ARGLU1 promotes tumorigenic potential of breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113491"}}